Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/25395
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorDENS, Jo-
dc.contributor.advisorWalsh, Simon-
dc.contributor.authorMAEREMANS, Joren-
dc.date.accessioned2018-01-08T09:56:56Z-
dc.date.available2018-01-08T09:56:56Z-
dc.date.issued2018-
dc.identifier.urihttp://hdl.handle.net/1942/25395-
dc.description.abstractCoronary chronic total occlusions are frequently encountered atherosclerotic lesions in patients with coronary artery disease. Although the efficiency of CTO-PCI in improving clinical outcomes is supported by trials, only 10% of these patients are treated via PCI. The low rate of invasive treatment mainly stems from the greater technical complexity and perceived higher risk of complications, which makes that CTOs are referred to as “the final frontier” of PCI. During recent years, more advanced (CTO-dedicated) devices, techniques, and algorithms have been developed to overcome these technical challenges. Yet, both the short- and long-term benefits of these developments on CTO-PCI outcomes remain to be validated in larger communities. In part I of this doctoral thesis, we demonstrated the improved procedural efficiency, safety, and applicability of the hybrid algorithm and the different contemporary wiring and dissection and re-entry techniques for a broader community. Moreover, we re-evaluated current CTO complexity scores and developed a novel scoring tool that copes with the current evolutions in CTO-PCI. In addition, we provided the first appraisal of the evolutions in the field of CTO-PCI in the BeLux landscape. In part II, we proved the efficiency of certain specific new and improved CTO-dedicated materials to address common failure modes in CTO-PCI. Besides this, we demonstrated the long-term satisfactory performance and safety of BRS in the setting of CTO-PCI. We also added novel insights regarding patient’ and staff’ radiation exposure during CTO-PCI and determined the benefits of radioprotective drapes in CTO-PCI. In the final part, we evaluated the long-term outcomes of current percutaneous CTO intervention, and found that the advent of the hybrid algorithm results in favorable one-year outcomes. Moreover, event rates were comparable between wiring and DR techniques, indicative of the improved safety and efficiency of these contemporary techniques in the hybrid setting. Finally, measured hs-TnT levels indicated that one-year MACCE rates were significantly greater in patients with significant troponin elevation. In turn, troponin elevation was more frequently associated with more complex techniques. The work performed in this doctoral thesis has generated significant insights in the field of CTO-PCI and provided the much-needed evidence to support the continued use of the various, contemporary techniques, materials, and algorithms by a broad community of operators. Ultimately, this might result in treatments being targeted specifically to the individual patient’s needs.-
dc.description.sponsorshipInvestigator-driven research grants provided by Boston Scientific, Abbott, Asahi Intecc co., IMDS, and BioTronik. Joren Maeremans was supported by a grant of the Special Research Foundation at Hasselt University (BOF15DOC38). This research was also part of the Limburg Clinical Research Program UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital.-
dc.language.isoen-
dc.subject.otherChronic Total Occlusions; percutaneous coronary intervention-
dc.titlePercutaneous Coronary Intervention of Chronic Total Occlusions: Exploring the Final Frontier-
dc.typeTheses and Dissertations-
local.format.pages290-
local.bibliographicCitation.jcatT1-
dc.relation.references1. Sianos G, Werner GS, Galassi AR, et al. Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. EuroIntervention 2012;8:139-45. 2. Guo J, Maehara A, Mintz GS, et al. A virtual histology intravascular ultrasound analysis of coronary chronic total occlusions. Catheter Cardiovasc Interv 2013;81:464-70. 3. Hoebers LP, Claessen BE, Dangas GD, Ramunddal T, Mehran R, Henriques JPS. Contemporary overview and clinical perspectives of chronic total occlusions. Nat Rev Cardiol 2014;11:458-469. 4. Roy S, Sharma J. "Role of CT Coronary Angiography in Recanalization of Chronic Total Occlusion". Current Cardiology Reviews 2015;11:317-322. 5. Srivatsa SS, Edwards WD, Boos CM, et al. Histologic Correlates of Angiographic Chronic Total Coronary Artery Occlusions: Influence of Occlusion Duration on Neovascular Channel Patterns and Intimal Plaque Composition. Journal of the American College of Cardiology 1997;29:955-963. 6. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012;59:991-7. 7. Bennett J, Kayaert P, Bataille Y, Dens J. Percutaneous coronary interventions of chronic total -occlusions; a review of clinical indications, treatment strategy and current practice. Acta Cardiol 2017;10.1080/00015385.2017.1335080:1-13. 8. Claessen BE, Dangas GD, Weisz G, et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial, 2012. 9. Lexis CP, van der Horst IC, Rahel BM, et al. Impact of chronic total occlusions on markers of reperfusion, infarct size, and long-term mortality: a substudy from the TAPAS-trial. Catheter Cardiovasc Interv 2011;77:484-91. 10. Bataille Y, Dery JP, Larose E, et al. Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction. Am Heart J 2012;164:509-15. 11. Hoebers LP, Vis MM, Claessen BE, et al. The impact of multivessel disease with and without a co-existing chronic total occlusion on short- and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock. Eur J Heart Fail 2013;15:425-32. 12. Choi JH, Chang SA, Choi JO, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries. Circulation 2013;127:703-9. 13. Werner GS, Fritzenwanger M, Prochnau D, et al. Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance. J Am Coll Cardiol 2006;48:51-8. 14. Jang WJ, Yang JH, Choi S-H, et al. Long-Term Survival Benefit of Revascularization Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion and Well-Developed Collateral Circulation. JACC: Cardiovascular Interventions 2015;8:271-279. 15. Stuijfzand WJ, Driessen RS, Raijmakers PG, et al. Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging 2016;10.1093/ehjci/jew188. 16. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv 2014;83:9-16. 17. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002. Eur Heart J 2005;26:2630-6. 18. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol 2001;38:409-14. 19. Barbato E, Wijns W. Are We Ready for a New Paradigm Shift in Percutaneous Revascularization of Chronically Occluded Vessels With Well-Developed Collaterals?: From Leaving ’Em All to Stenting ’Em All∗. JACC: Cardiovascular Interventions 2015;8:280-282. 20. Valenti R, Migliorini A, Signorini U, et al. Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion. Eur Heart J 2008;29:2336-42. 21. Hoebers LP, Claessen BE, Elias J, Dangas GD, Mehran R, Henriques JPS. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. International Journal of Cardiology 2015;187:90-96. 22. Kirschbaum SW, Baks T, van den Ent M, et al. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions. Am J Cardiol 2008;101:179-85. 23. Borgia F, Viceconte N, Ali O, et al. Improved cardiac survival, freedom from MACE and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions. Int J Cardiol 2012;161:31-8. 24. George S, Cockburn J, Clayton TC, et al. Long-Term Follow-Up of Elective Chronic Total Coronary Occlusion Angioplasty: Analysis From the U.K. Central Cardiac Audit Database. Journal of the American College of Cardiology 2014;64:235-243. 25. Wijeysundera HC, Norris C, Fefer P, et al. Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions. EuroIntervention 2014;9:1165-72. 26. Galassi AR, Sianos G, Werner GS, et al. Retrograde Recanalization of Chronic Total Occlusions in Europe: Procedural, In-Hospital, and Long-Term Outcomes From the Multicenter ERCTO Registry. J Am Coll Cardiol 2015;65:2388-2400. 27. Michael TT, Karmpaliotis D, Brilakis ES, et al. Procedural outcomes of revascularization of chronic total occlusion of native coronary arteries (from a multicenter United States registry). Am J Cardiol 2013;112:488-92. 28. Nombela-Franco L, Mitroi CD, Fernandez-Lozano I, et al. Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study). Circ Arrhythm Electrophysiol 2012;5:147-54. 29. Yang ZK, Zhang RY, Hu J, Zhang Q, Ding FH, Shen WF. Impact of successful staged revascularization of a chronic total occlusion in the non-infarct-related artery on long-term outcome in patients with acute ST-segment elevation myocardial infarction. Int J Cardiol 2013;165:76-9. 30. Henriques JP, Hoebers LP, Ramunddal T, et al. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. J Am Coll Cardiol 2016;68:1622-1632. 31. Mehran R, Claessen BE, Godino C, et al. Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv 2011;4:952-61. 32. Jones DA, Weerackody R, Rathod K, et al. Successful recanalization of chronic total occlusions is associated with improved long-term survival. JACC Cardiovasc Interv 2012;5:380-8. 33. Galassi AR, Werner GS, Tomasello SD, et al. Prognostic value of exercise myocardial scintigraphy in patients with coronary chronic total occlusions. J Interv Cardiol 2010;23:139-48. 34. Galassi AR, Grantham A, Kandzari D, et al. Percutaneous treatment of coronary chronic total occlusion. Part 2: technical approach. Interventional Cardiology Review 2014;9:201-7. 35. Whitlow PL, Burke MN, Lombardi WL, et al. Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial. JACC Cardiovasc Interv 2012;5:393-401. 36. Werner GS, Schofer J, Sievert H, Kugler C, Reifart NJ. Multicentre experience with the BridgePoint devices to facilitate recanalisation of chronic total coronary occlusions through controlled subintimal re-entry. EuroIntervention 2011;7:192-200. 37. Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Subintimal Dissection/Reentry Strategies in Coronary Chronic Total Occlusion Interventions. Circ Cardiovasc Interv 2012;5:729-738. 38. Rathore S, Katoh O, Matsuo H, et al. Retrograde percutaneous recanalization of chronic total occlusion of the coronary arteries: procedural outcomes and predictors of success in contemporary practice. Circ Cardiovasc Interv 2009;2:124-32. 39. Saito S. Different strategies of retrograde approach in coronary angioplasty for chronic total occlusion. Catheter Cardiovasc Interv 2008;71:8-19. 40. Brilakis ES, Grantham JA, Thompson CA, et al. The retrograde approach to coronary artery chronic total occlusions: a practical approach. Catheter Cardiovasc Interv 2012;79:3-19. 41. Joyal D, Thompson CA, Grantham JA, Buller CE, Rinfret S. The retrograde technique for recanalization of chronic total occlusions: a step-by-step approach. JACC Cardiovasc Interv 2012;5:1-11. 42. Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. J Am Coll Cardiol Intv 2012;5:367-79. 43. Maeremans J, Walsh S, Knaapen P, et al. The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry. J Am Coll Cardiol 2016;68:1958-1970. 44. Brilakis E, Karmpaliotis D, Vo M, et al. Advances in the Management of Coronary Chronic Total Occlusions. Journal of Cardiovascular Translational Research 2014;10.1007/s12265-014-9556-6:1-11. 45. Brilakis ES, Badhey N, Banerjee S. "Bilateral knuckle" technique and Stingray re-entry system for retrograde chronic total occlusion intervention. J Invasive Cardiol 2011;23:E37-9. 46. Michael TT, Mogabgab O, Fuh E, et al. Application of the “Hybrid Approach” to Chronic Total Occlusion Interventions: A Detailed Procedural Analysis. Journal of Interventional Cardiology 2014;27:36-43. 47. Papayannis A, Banerjee S, Brilakis ES. Use of the Crossboss catheter in coronary chronic total occlusion due to in-stent restenosis. Catheter Cardiovasc Interv 2012;80:E30-6. 48. Tsuchikane E, Yamane M, Mutoh M, et al. Japanese multicenter registry evaluating the retrograde approach for chronic coronary total occlusion. Catheter Cardiovasc Interv 2013;82:E654-61. 49. Sianos G, Barlis P, Di Mario C, et al. European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club. EuroIntervention 2008;4:84-92. 50. Sheiban I, Moretti C, Biondi-Zoccai GG, et al. Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery. Journal of Cardiovascular Medicine 2008;9:213-216. 51. Maeremans J, Selleslagh P, Di Serafino L, Barbato E, Dens J. Chronic total occlusions for intermediate volume operators: An antegrade step-up algorithm allows high success in easy and intermediate difficult CTO lesions. WJCD 2013;3:536-42. 52. Nassar YS, Boudou N, Dumonteil N, Lhermusier T, Carrie D. Guidewires used in first intentional single wiring strategy for chronic total occlusions of the left anterior descending coronary artery. Heart Views 2013;14:56-61. 53. Fujino A, Sakamoto H, Fujino M, et al. The Procedural Benefit of Soft and Tapered Tip Guidewire use as a first choice for Chronic Total Occlusion Revascularization. Journal of the American College of Cardiology 2012;59:E106. 54. Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. J Am Coll Cardiol Intv 2011;4:213-21. 55. Di Serafino L, Borgia F, Maeremans J, et al. The Age, Creatinine, and Ejection Fraction Score to Risk Stratify Patients Who Underwent Percutaneous Coronary Intervention of Coronary Chronic Total Occlusion. The American Journal of Cardiology 2014;114:1158-1164. 56. Syrseloudis D, Secco GG, Barrero EA, et al. Increase in J-CTO lesion complexity score explains the disparity between recanalisation success and evolution of chronic total occlusion strategies: insights from a single-centre 10-year experience. Heart 2013;99:474-9. 57. Joseph G, Thomson VS, Radhakrishnan S. Corsair microcatheter for retrograde coronary chronic total occlusion recanalization: early experience outside the realm of dedicated recanalization specialists. Indian Heart J 2012;64:388-93. 58. Otsuka Y, Nakamura K, Saito T. Usefulness of the Corsair Microcatheter for Treatment of Complex Chronic Total Occlusion. J Invasive Cardiol 2012;24:E35-8. 59. Takagi K, Ielasi A, Chieffo A, et al. Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry. Circ Cardiovasc Interv 2013;6:154-60. 60. Aziz S, Stables RH, Grayson AD, Perry RA, Ramsdale DR. Percutaneous coronary intervention for chronic total occlusions: Improved survival for patients with successful revascularization compared to a failed procedure. Catheterization and Cardiovascular Interventions 2007;70:15-20. 61. Rathore S, Matsuo H, Terashima M, et al. Procedural and In-Hospital Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions of Coronary Arteries 2002 to 2008: Impact of Novel Guidewire Techniques. JACC: Cardiovascular Interventions 2009;2:489-497. 62. Rinfret S, Joyal D, Spratt JC, Buller CE. Chronic total occlusion percutaneous coronary intervention case selection and techniques for the antegrade-only operator. Catheterization and Cardiovascular Interventions 2015;85:408-415. 63. Maeremans J, Knaapen P, Stuijfzand WJ, et al. Antegrade wire escalation for chronic total occlusions in coronary arteries: simple algorithms as a key to success. J Cardiovasc Med (Hagerstown) 2015;10.2459/jcm.0000000000000340. 64. Azzalini L, Vo M, Dens J, Agostoni P. Myths to Debunk to Improve Management, Referral, and Outcomes in Patients With Chronic Total Occlusion of an Epicardial Coronary Artery. Am J Cardiol 2015;116:1774-80. 65. Thompson CA. The Hybrid Approach for Percutaneous Revascularization of Coronary Chronic Total Occlusions. Interventional Cardiology Clinics 2012;1:349-353. 66. Christopoulos G, Menon RV, Karmpaliotis D, et al. Application of the “Hybrid Approach” to Chronic Total Occlusions in Patients With Previous Coronary Artery Bypass Graft Surgery (from a Contemporary Multicenter US Registry). The American Journal of Cardiology 2014;113:1990-1994. 67. Christopoulos G, Karmpaliotis D, Alaswad K, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol 2015;198:222-228. 68. Shammas NW, Shammas GA, Robken J, et al. The learning curve in treating coronary chronic total occlusion early in the experience of an operator at a tertiary medical center: The role of the hybrid approach. Cardiovasc Revasc Med 2016;17:15-8. 69. Christopoulos G, Karmpaliotis D, Alaswad K, et al. The efficacy of "hybrid" percutaneous coronary intervention in chronic total occlusions caused by in-stent restenosis: insights from a US multicenter registry. Catheter Cardiovasc Interv 2014;84:646-51. 70. Pershad A, Eddin M, Girotra S, Cotugno R, Daniels D, Lombardi W. Validation and incremental value of the hybrid algorithm for CTO PCI. Catheter Cardiovasc Interv 2014;84:654-9. 71. Sabbagh AE, Banerjee S, Brilakis ES. Illustration of the ‘hybrid’ approach to chronic total occlusion crossing. Interventional Cardiology 2012;4:639-643. 72. Christopoulos G, Menon RV, Karmpaliotis D, et al. The efficacy and safety of the "hybrid" approach to coronary chronic total occlusions: insights from a contemporary multicenter US registry and comparison with prior studies. J Invasive Cardiol 2014;26:427-32. 73. Nombela-Franco L, Urena M, Jerez-Valero M, et al. Validation of the J-Chronic Total Occlusion Score for Chronic Total Occlusion Percutaneous Coronary Intervention in an Independent Contemporary Cohort. Circulation: Cardiovascular Interventions 2013;6:635-643. 74. Christopoulos G, Kandzari DE, Yeh RW, et al. Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score. J Am Coll Cardiol Intv 2016;9:1-9. 75. Colombo A, Mikhail GW, Michev I, et al. Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique. Catheter Cardiovasc Interv 2005;64:407-11; discussion 412. 76. Sharma V, Jadhav ST, Harcombe AA, et al. Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions. Open Heart 2015;2. 77. Vo MN, Christopoulos G, Karmpaliotis D, Lombardi WL, Grantham JA, Brilakis ES. Balloon-Assisted Microdissection "BAM" Technique for Balloon-Uncrossable Chronic Total Occlusions. J Invasive Cardiol 2016;28:E37-41. 78. Vo MN, Karmpaliotis D, Brilakis ES. “Move the cap” technique for ambiguous or impenetrable proximal cap of coronary total occlusion. Catheterization and Cardiovascular Interventions 2016;87:742-748. 79. Rinfret S. Percutaneous Intervention for Coronary Chronic Total Occlusion: the Hybrid approach. 1st ed. Switserland: Springer International Publishing, 2016. 80. Galassi AR, Tomasello SD, Reifart N, et al. In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention 2011;7:472-9. 81. Dautov R, Manh Nguyen C, Altisent O, Gibrat C, Rinfret S. Recanalization of Chronic Total Occlusions in Patients With Previous Coronary Bypass Surgery and Consideration of Retrograde Access via Saphenous Vein Grafts. Circ Cardiovasc Interv 2016;9:e003515. 82. Habara M, Tsuchikane E, Muramatsu T, et al. Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry. Catheterization and Cardiovascular Interventions 2015;10.1002/ccd.26354:n/a-n/a. 83. Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv 2013;6:128-36. 84. Hannan EL, Zhong Y, Jacobs AK, et al. Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Interventions: Characteristics, Success, and Outcomes. Circ Cardiovasc Interv 2016;9:e003586. 85. Habara M, Tsuchikane E, Muramatsu T, et al. Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry. Catheter Cardiovasc Interv 2016;87:1027-35. 86. Karmpaliotis D, Michael TT, Brilakis ES, et al. Retrograde coronary chronic total occlusion revascularization: procedural and in-hospital outcomes from a multicenter registry in the United States. JACC Cardiovasc Interv 2012;5:1273-9. 87. Karmpaliotis D, Karatasakis A, Alaswad K, et al. Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry. Circ Cardiovasc Interv 2016;9:e003434. 88. Tsujita K, Maehara A, Mintz GS, et al. Intravascular Ultrasound Comparison of the Retrograde Versus Antegrade Approach to Percutaneous Intervention for Chronic Total Coronary Occlusions. JACC Cardiovasc Interv 2009;2:846-854. 89. McEntegart MB, Badar AA, Ahmad FA, et al. The collateral circulation of coronary chronic total occlusions. Eurointervention 2016;11:e1596-603. 90. Bolia A, Brennan J, Bell PR. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 1989;40:325. 91. Godino C, Latib A, Economou FI, et al. Coronary chronic total occlusions: mid-term comparison of clinical outcome following the use of the guided-STAR technique and conventional anterograde approaches. Catheter Cardiovasc Interv 2012;79:20-7. 92. Galassi AR, Tomasello SD, Costanzo L, et al. Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion. Catheter Cardiovasc Interv 2012;79:30-40. 93. Galassi AR, Boukhris M, Tomasello SD, et al. Long-term Clinical and Angiographic Outcomes of the Mini-STAR Technique as a Bailout Strategy for Percutaneous Coronary Intervention of Chronic Total Occlusion. Can J Cardiol 2014;30:1400-1406. 94. Wilson WM, Walsh S, Hanratty C, et al. A novel approach to the management of occlusive in-stent restenosis (ISR). EuroIntervention 2014;9:1285-93. 95. Carlino M, Godino C, Latib A, Moses JW, Colombo A. Subintimal tracking and re-entry technique with contrast guidance: a safer approach. Catheter Cardiovasc Interv 2008;72:790-6. 96. Danek BA, Karatasakis A, Karmpaliotis D, et al. Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry. Int J Cardiol 2016;214:428-37. 97. Carlino M, Figini F, Ruparelia N, et al. Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade. Catheter Cardiovasc Interv 2016;87:884-92. 98. Wu EB, Ikari Y. Stingray balloon used in slender percutaneous coronary intervention for chronic total occlusion. J Invasive Cardiol 2013;25:E155-8. 99. Mogabgab O, Patel VG, Michael TT, et al. Long-term outcomes with use of the CrossBoss and stingray coronary CTO crossing and re-entry devices. J Invasive Cardiol 2013;25:579-85. 100. Carlino M, Ruparelia N, Thomas G, et al. Modified contrast microinjection technique to facilitate chronic total occlusion recanalization. Catheter Cardiovasc Interv 2016;87:1036-41. 101. Wilson WM, Walsh SJ, Yan AT, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart 2016;102:1486-93. 102. Azzalini L, Dautov R, Brilakis ES, et al. Procedural and longer-term outcomes of wire- versus device-based antegrade dissection and re-entry techniques for the percutaneous revascularization of coronary chronic total occlusions. Int J Cardiol 2017;231:78-83. 103. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-56. 104. Ferrante G, Rao SV, Juni P, et al. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv 2016;9:1419-34. 105. Wimmer NJ, Secemsky EA, Mauri L, et al. Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis. Circ Cardiovasc Interv 2016;9:e003464. 106. Rathore S, Hakeem A, Pauriah M, Roberts E, Beaumont A, Morris JL. A comparison of the transradial and the transfemoral approach in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv 2009;73:883-7. 107. Alaswad K, Menon RV, Christopoulos G, et al. Transradial approach for coronary chronic total occlusion interventions: Insights from a contemporary multicenter registry. Catheter Cardiovasc Interv 2015;85:1123-9. 108. Rinfret S, Joyal D, Nguyen CM, et al. Retrograde recanalization of chronic total occlusions from the transradial approach; early Canadian experience. Catheter Cardiovasc Interv 2011;78:366-74. 109. Yang CH, Guo GB, Chen SM, et al. Feasibility and safety of a transradial approach in intervention for chronic total occlusion of coronary arteries: a single-center experience. Chang Gung Med J 2010;33:639-45. 110. Tanaka Y, Moriyama N, Ochiai T, et al. Transradial Coronary Interventions for Complex Chronic Total Occlusions. JACC Cardiovasc Interv 2017;10:235-243. 111. Hoye A. Management of chronic total occlusion by percutaneous coronary intervention. Heart 2012;98:822-8. 112. Burzotta F, De Vita M, Lefevre T, Tommasino A, Louvard Y, Trani C. Radial approach for percutaneous coronary interventions on chronic total occlusions: technical issues and data review. Catheter Cardiovasc Interv 2014;83:47-57. 113. Dautov R, Ribeiro HB, Abdul-Jawad Altisent O, et al. Effectiveness and Safety of the Transradial 8Fr Sheathless Approach for Revascularization of Chronic Total Occlusions. Am J Cardiol 2016;118:785-9. 114. Maeremans J, Selleslagh P, Di Serafino L, Barbato E, Dens J. Impact of negative lesion characteristics of chronic total occlusions on procedural outcome and strategy. Acta Cardiol 2013;68:455-61. 115. Tanaka H, Morino Y, Abe M, et al. Impact of J-CTO score on procedural outcome and target lesion revascularisation after percutaneous coronary intervention for chronic total occlusion: a substudy of the J-CTO Registry (Multicentre CTO Registry in Japan). EuroIntervention 2016;11:981-8. 116. Karatasakis A, Danek B, Karmpaliotis D, et al. Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry. Journal of Invasive Cardiology 2016;28:391-396. 117. Karatasakis A, Danek BA, Karmpaliotis D, et al. Comparison of various scores for predicting success of chronic total occlusion percutaneous coronary intervention. Int J Cardiol 2016;224:50-56. 118. Galassi AR, Boukhris M, Azzarelli S, Castaing M, Marza F, Tomasello SD. Percutaneous Coronary Revascularization for Chronic Total Occlusions: A Novel Predictive Score of Technical Failure Using Advanced Technologies. JACC Cardiovasc Interv 2016;9:911-22. 119. Alessandrino G, Chevalier B, Lefèvre T, et al. A Clinical and Angiographic Scoring System to Predict the Probability of Successful First-Attempt Percutaneous Coronary Intervention in Patients With Total Chronic Coronary Occlusion. JACC: Cardiovascular Interventions 2015;8:1540-1548. 120. Wilson WM, Walsh SJ, Yan AT, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart 2016;10.1136/heartjnl-2015-308891:In Press. 121. Abbas AE, Brewington SD, Dixon SR, Boura J, Grines CL, O’Neill WW. Success, Safety, and Mechanisms of Failure of Percutaneous Coronary Intervention for Occlusive Non–Drug-Eluting In-Stent Restenosis Versus Native Artery Total Occlusion. The American Journal of Cardiology 2005;95:1462-1466. 122. Karacsonyi J, Karatasakis A, Karmpaliotis D, et al. Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry). Am J Cardiol 2016;117:1267-71. 123. Abdel-karim AR, Lombardi WB, Banerjee S, Brilakis ES. Contemporary outcomes of percutaneous intervention in chronic total coronary occlusions due to in-stent restenosis. Cardiovasc Revasc Med 2011;12:170-6. 124. Michael TT, Karmpaliotis D, Brilakis ES, et al. Impact of prior coronary artery bypass graft surgery on chronic total occlusion revascularisation: insights from a multicentre US registry. Heart 2013;99:1515-1518. 125. Teramoto T, Tsuchikane E, Matsuo H, et al. Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery. J Am Coll Cardiol Intv 2014;7:39-46. 126. Christopoulos G, Wyman RM, Alaswad K, et al. Clinical Utility of the Japan-Chronic Total Occlusion Score in Coronary Chronic Total Occlusion Interventions: Results from a Multicenter Registry. Circ Cardiovasc Interv 2015;8. 127. Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-Analysis of Clinical Outcomes of Patients Who Underwent Percutaneous Coronary Interventions for Chronic Total Occlusions. The American Journal of Cardiology 2015;115:1367-1375. 128. Werner G. A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO). EuroIntervention 2017;Abstract presented at EuroPCR congress 2017. 129. Azzalini L, Dautov R, Brilakis ES, et al. Impact of crossing strategy on mid-term outcomes following percutaneous revascularisation of coronary chronic total occlusions. EuroIntervention 2017;10.4244/eij-d-16-01010. 130. Tsai TT, Stanislawski MA, Shunk KA, et al. Contemporary Incidence, Management, and Long-Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total Occlusions: Insights From the VA CART Program. JACC Cardiovasc Interv 2017;10:866-875. 131. Mehran R, Rao SV, Bhatt DL, et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium. Circulation 2011;123:2736-2747. 132. Park SJ. Drug-eluting stent versus optimal medical therapy in patients with coronary chronic total occlusion: DECISION CTO randomized trial. Journal of the American College of Cardiology 2017;Presented at: ACC 2017. March 18, 2017. Washington, DC. 133. Råmunddal T, Hoebers L, Henriques JPS, et al. Chronic Total Occlusions in Sweden – A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS ONE 2014;9:e103850. 134. Abbott JD, Kip KE, Vlachos HA, et al. Recent trends in the percutaneous treatment of chronic total coronary occlusions. Am J Cardiol 2006;97:1691-6. 135. Grantham JA, Marso SP, Spertus J, House J, Holmes DR, Jr., Rutherford BD. Chronic total occlusion angioplasty in the United States. JACC Cardiovasc Interv 2009;2:479-86. 136. Patel VG, Brayton KM, Tamayo A, et al. Angiographic Success and Procedural Complications in Patients Undergoing Percutaneous Coronary Chronic Total Occlusion Interventions: A Weighted Meta-Analysis of 18,061 Patients From 65 Studies. JACC: Cardiovascular Interventions 2013;6:128-136. 137. Grantham JA, Jones PG, Cannon L, Spertus JA. Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial. Circ Cardiovasc Qual Outcomes 2010;3:284-90. 138. Danzi GB, Valenti R, Migliorini A, Parodi G, Vergara R, Antoniucci D. Percutaneous Coronary Intervention for Multiple Chronic Total Occlusions. The American Journal of Cardiology 2013;112:1849-1853. 139. Olivari Z, Rubartelli P, Piscione F, et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol 2003;41:1672-8. 140. Chung CM, Nakamura S, Tanaka K, et al. Effect of recanalization of chronic total occlusions on global and regional left ventricular function in patients with or without previous myocardial infarction. Catheter Cardiovasc Interv 2003;60:368-74. 141. Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 2005;112:2364-72. 142. Stone GW, Reifart NJ, Moussa I, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation 2005;112:2530-7. 143. Noguchi T, Miyazaki MS, Morii I, Daikoku S, Goto Y, Nonogi H. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Catheter Cardiovasc Interv 2000;49:258-64. 144. Thompson CA, Jayne JE, Robb JF, et al. Retrograde techniques and the impact of operator volume on percutaneous intervention for coronary chronic total occlusions an early U.S. experience. JACC Cardiovasc Interv 2009;2:834-42. 145. Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report From the NCDR (National Cardiovascular Data Registry). JACC: Cardiovascular Interventions 2015;8:245-253. 146. Fefer P, Strauss BH. Climbing PCI success rates in complex chronic total occlusions: joining "The Club". EuroIntervention 2011;7:421-3. 147. Werner GS. The BridgePoint devices to facilitate recanalization of chronic total coronary occlusions through controlled subintimal reentry. Expert Rev Med Devices 2011;8:23-9. 148. Surmely JF, Tsuchikane E, Katoh O, et al. New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: the CART technique. J Invasive Cardiol 2006;18:334-8. 149. Mozid AM, Davies JR, Spratt JC. The utility of a guideliner catheter in retrograde percutaneous coronary intervention of a chronic total occlusion with reverse cart-the "capture" technique. Catheter Cardiovasc Interv 2014;83:929-32. 150. Serruys PW, Ormiston JA, Onuma Y, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910. 151. Serruys PW, Ormiston J, van Geuns RJ, et al. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up. J Am Coll Cardiol 2016;67:766-76. 152. Serruys PW, Chevalier B, Dudek D, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet 2015;385:43-54. 153. Ellis SG, Kereiakes DJ, Metzger DC, et al. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med 2015;373:1905-15. 154. Gao R, Yang Y, Han Y, et al. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial. J Am Coll Cardiol 2015;66:2298-309. 155. Kimura T, Kozuma K, Tanabe K, et al. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J 2015;36:3332-42. 156. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR, Jr. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol 2007;49:1611-8. 157. Vaquerizo B, Barros A, Pujadas S, et al. One-Year Results of Bioresorbable Vascular Scaffolds for Coronary Chronic Total Occlusions. Am J Cardiol 2016;117:906-917. 158. Vaquerizo B, Barros A, Pujadas S, et al. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study. EuroIntervention 2015;11:555-563. 159. Azzalini L, Giustino G, Ojeda S, et al. Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions). Circ Cardiovasc Interv 2016;9. 160. Yamac AH, Yildiz A, Nasifov M, Tastan A, Bashirov N, Goktekin O. Clinical and angiographic outcomes at more than 1 year after treatment of chronic total occlusions with the everolimus-eluting bioresorbable vascular scaffold. Turk Kardiyol Dern Ars 2016;44:647-655. 161. Naganuma T, Latib A, Panoulas VF, et al. One-year follow-up optical coherence tomography after implantation of bioresorbable vascular scaffolds for a chronic coronary total occlusion. JACC Cardiovasc Interv 2014;7:e157-9. 162. Goktekin O, Yamac AH, Latib A, et al. Evaluation of the Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold (BVS) Implantation in Patients With Chronic Total Coronary Occlusions: Acute Procedural and Short-Term Clinical Results. J Invasive Cardiol 2015;27:461-6. 163. Mitomo S, Naganuma T, Fujino Y, et al. Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry. Circ Cardiovasc Interv 2017;10. 164. Wiebe J, Liebetrau C, Dörr O, et al. Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion. Int J Cardiol 2015;179:90-94. 165. Ojeda S, Pan M, Romero M, et al. Outcomes and Computed Tomography Scan Follow-Up of Bioresorbable Vascular Scaffold for the Percutaneous Treatment of Chronic Total Coronary Artery Occlusion. Am J Cardiol 2015;115:1487-1493. 166. Lesiak M, Lanocha M, Araszkiewicz A, et al. Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry. EuroIntervention 2016;12:e144-51. 167. Ormiston JA, Serruys PW, Onuma Y, et al. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ Cardiovasc Interv 2012;5:620-32. 168. Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation 2007;115:2344-2351. 169. Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011;123:779-97. 170. Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P. Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J 2014;35:765-76. 171. Basavarajaiah S, Naganuma T, Latib A, et al. Extended follow-up following "full-metal jacket" percutaneous coronary interventions with drug-eluting stents. Cath Cardiovasc Interv 2014;84:1042-50. 172. Serruys PW, Chevalier B, Sotomi Y, et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. The Lancet;388:2479-2491. 173. Collet C, Asano T, Sotomi Y, et al. Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. Minerva Cardioangiol 2017;65:32-51. 174. Karanasos A, Van Mieghem N, van Ditzhuijzen N, et al. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience. Circ Cardiovasc Interv 2015;8. 175. Raber L, Brugaletta S, Yamaji K, et al. Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings. J Am Coll Cardiol 2015;66:1901-14. 176. Sotomi Y, Suwannasom P, Serruys PW, Onuma Y. Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging. EuroIntervention 2017;12:1747-1756. 177. Wykrzykowska JJ, Kraak RP, Hofma SH, et al. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI. N Engl J Med 2017;10.1056/NEJMoa1614954. 178. Capodanno D, Gori T, Nef H, et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention 2015;10:1144-53. 179. Bruining N, Tanimoto S, Otsuka M, et al. Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CA. EuroIntervention 2008;4:285-91. 180. Onuma Y, Dudek D, Thuesen L, et al. Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease: The ABSORB Cohort A Trial. JACC Cardiovasc Interv 2013;6:999-1009. 181. Onuma Y, Collet C, van Geuns RJ, et al. Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy. Eur Heart J Cardiovasc Imaging 2017;10.1093/ehjci/jex022. 182. Cortese B, Piraino D, Latini RA, et al. Final shape of biovascular scaffolds and clinical outcome. Results from a multicenter all-comers study with intravascular imaging. Int J Cardiol 2017;228:209-213. 183. Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ. Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair. Radiology 2010;254:326-41. 184. Vanhavere F, Carinou E, Domienik J, et al. Measurements of eye lens doses in interventional radiology and cardiology: Final results of the ORAMED project. Radiation Measurements 2011;46:1243-1247. 185. Carinou E, Ginjaume M, O'Connor U, Kopec R, Sans Merce M. Status of eye lens radiation dose monitoring in European hospitals. J Radiol Prot 2014;34:729-39. 186. International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332. 187. Stewart FA, Akleyev AV, Hauer-Jensen M, et al. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context. Ann ICRP 2012;41:1-322. 188. Shorrock D, Christopoulos G, Wosik J, et al. Impact of a Disposable Sterile Radiation Shield on Operator Radiation Exposure During Percutaneous Coronary Intervention of Chronic Total Occlusions. J Invasive Cardiol 2015;27:313-6. 189. Alazzoni A, Gordon CL, Syed J, et al. Randomized Controlled Trial of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap for Operators Performing Coronary Angiography or Intervention. Circ Cardiovasc Interv 2015;8:e002384. 190. Murphy JC, Darragh K, Walsh SJ, Hanratty CG. Efficacy of the RADPAD Protective Drape During Real World Complex Percutaneous Coronary Intervention Procedures. The American Journal of Cardiology 2011;108:1408-1410. 191. Dabin J, Negri A, Farah J, et al. Characterisation of grids of point detectors in maximum skin dose measurement in fluoroscopically-guided interventional procedures. Phys Med 2015;31:1112-7. 192. Commission IE. Medical diagnostic X-ray equipment - Radiation conditions for use in the determination of characteristics IEC 61267. 2005. 193. Donadille L, Carinou E, Brodecki M, et al. Staff eye lens and extremity exposure in interventional cardiology: Results of the ORAMED project. Radiation Measurements 2011;46:1203-1209. 194. Standardization IOf. X and gamma reference radiation for calibrating dosemeters and doserate meters and for determining their response as a function of photon energy - Part 4: Calibration of area and personal dosemeters in low energy X reference radiation fields. ISO 4037-4. 2004. 195. Metrology. JCfGi. Evaluation of measurement data - Guide to the expression of uncertainty in measurement (GUM). 2008. 196. Domienik J, Papierz S, Jankowski J, Peruga JZ, Werduch A, Religa W. Correlation of patient maximum skin doses in cardiac procedures with various dose indicators. Radiat Prot Dosimetry 2008;132:18-24. 197. Bogaert E, Bacher K, Lemmens K, et al. A large-scale multicentre study of patient skin doses in interventional cardiology: dose-area product action levels and dose reference levels. Br J Radiol 2009;82:303-12. 198. Journy N, Sinno-Tellier S, Maccia C, et al. Main clinical, therapeutic and technical factors related to patient's maximum skin dose in interventional cardiology procedures. Br J Radiol 2012;85:433-42. 199. Suzuki S, Furui S, Isshiki T, et al. Patients' skin dose during percutaneous coronary intervention for chronic total occlusion. Catheter Cardiovasc Interv 2008;71:160-4. 200. Miller DL, Balter S, Schueler BA, Wagner LK, Strauss KJ, Vano E. Clinical radiation management for fluoroscopically guided interventional procedures. Radiology 2010;257:321-32. 201. Miller DL, Vano E, Bartal G, et al. Occupational radiation protection in interventional radiology: a joint guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of Interventional Radiology. Cardiovasc Intervent Radiol 2010;33:230-9. 202. Valenti R, Vergara R, Migliorini A, et al. Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion. J Am Coll Cardiol 2013;61:545-50. 203. Amsavelu S, Christakopoulos GE, Karatasakis A, et al. Impact of Crossing Strategy on Intermediate-term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention. Can J Cardiol 2016;32:1239.e1-1239.e7. 204. Rinfret S, Ribeiro HB, Nguyen CM, Nombela-Franco L, Ureña M, Rodés-Cabau J. Dissection and Re-Entry Techniques and Longer-Term Outcomes Following Successful Percutaneous Coronary Intervention of Chronic Total Occlusion. The American Journal of Cardiology 2014;114:1354-1360. 205. Bijuklic K, Schwencke C, Schofer J. Long-term major adverse cardiac and cerebrovascular events (MACCE) rate : Comparison of retrograde and antegrade recanalization of chronic total coronary occlusions. Wien Klin Wochenschr 2017;129:243-250. 206. Wilson WM, Walsh SJ, Bagnall A, et al. One-year outcomes after successful chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv 2017;10.1002/ccd.26980. 207. Maeremans J, Spratt JC, Knaapen P, et al. Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE score. Catheter Cardiovasc Interv 2017;10.1002/ccd.27092. 208. Toma A, Stähli BE, Gick M, et al. Long-Term Follow-Up of Patients With Previous Coronary Artery Bypass Grafting Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion. The American Journal of Cardiology 2016;118:1641-1646. 209. Pereg D, Fefer P, Samuel M, et al. Long-term Follow-up of Coronary Artery Bypass Patients With Preoperative and New Postoperative Native Coronary Artery Chronic Total Occlusion. Can J Cardiol 2016;32:1326-1331. 210. Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013;62:1421-31. 211. Claessen BE, van der Schaaf RJ, Verouden NJ, et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. J Am Coll Cardiol Intv 2009;2:1128-34. 212. Safley DM, Koshy S, Grantham JA, et al. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv 2011;78:337-43. 213. Danchin N, Angioi M, Cador R, et al. Effect of late percutaneous angioplastic recanalization of total coronary artery occlusion on left ventricular remodeling, ejection fraction, and regional wall motion. Am J Cardiol 1996;78:729-35. 214. Sirnes PA, Myreng Y, Molstad P, Bonarjee V, Golf S. Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions. Eur Heart J 1998;19:273-81. 215. Mashayekhi K, Neuser H, Kraus A, et al. Successful Percutaneous Coronary Intervention Improves Cardiopulmonary Exercise Capacity in Patients With Chronic Total Occlusions. Journal of the American College of Cardiology 2017;69:1095-1096. 216. Maeremans J, Dens J, Spratt JC, et al. Antegrade Dissection and Reentry as Part of the Hybrid Chronic Total Occlusion Revascularization Strategy: A Subanalysis of the RECHARGE Registry (Registry of CrossBoss and Hybrid Procedures in France, the Netherlands, Belgium and United Kingdom). Circ Cardiovasc Interv 2017;10. 217. Muramatsu T, Tsuchikane E, Oikawa Y, et al. Incidence and impact on midterm outcome of controlled subintimal tracking in patients with successful recanalisation of chronic total occlusions: J-PROCTOR registry. EuroIntervention 2014;10:681-8. 218. Michael TT, Mogabgab O, Alomar M, et al. Long-term outcomes of successful chronic total occlusion percutaneous coronary interventions using the antegrade and retrograde approach. J Interv Cardiol 2014;27:465-71. 219. Hasegawa K, Tsuchikane E, Okamura A, et al. Incidence and impact on midterm outcome of intimal versus subintimal tracking with both antegrade and retrograde approach in patients with successful recanalization of chronic total occlusions: J-PROCTOR2 study. EuroIntervention 2016;10.4244/eij-d-16-00557. 220. Ndrepepa G, Braun S, Cassese S, et al. Prognostic Value of High-sensitivity Troponin T After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. Rev Esp Cardiol (Engl Ed) 2016;69:746-53. 221. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR, Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv 2008;1:10-9. 222. Feldman DN, Kim L, Rene AG, Minutello RM, Bergman G, Wong SC. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 2011;77:1020-30. 223. Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis. Catheter Cardiovasc Interv 2008;71:318-24. 224. Toma A, Stahli B, Gebhard C, et al. Clinical Implications of Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion: Role of Antegrade and Retrograde Crossing Techniques. EuroIntervention 2017;10.4244/eij-d-17-00338. 225. Di Serafino L, Borgia F, Maeremans J, et al. Periprocedural Myocardial Injury and Long-Term Clinical Outcome in Patients Undergoing Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion. J Invasive Cardiol 2016;28:410-414. 226. Lo N, Michael TT, Moin D, et al. Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study. JACC Cardiovasc Interv 2014;7:47-54. 227. Kim SM, Gwon HC, Lee HJ, et al. Periprocedural myocardial infarction after retrograde approach for chronic total occlusion of coronary artery: demonstrated by cardiac magnetic resonance imaging. Korean Circ J 2011;41:747-9. 228. Werner GS, Coenen A, Tischer KH. Periprocedural ischaemia during recanalisation of chronic total coronary occlusions: the influence of the transcollateral retrograde approach. EuroIntervention 2014;10:799-805. 229. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-35. 230. Ndrepepa G, Colleran R, Braun S, et al. High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention. J Am Coll Cardiol 2016;68:2259-2268. 231. Ndrepepa G, Braun S, Schulz S, Mehilli J, Schomig A, Kastrati A. High-sensitivity troponin T level and angiographic severity of coronary artery disease. Am J Cardiol 2011;108:639-43. 232. Korosoglou G, Lehrke S, Mueller D, et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011;97:823-31.-
local.type.refereedNon-Refereed-
local.type.specifiedPhd thesis-
item.contributorMAEREMANS, Joren-
item.fullcitationMAEREMANS, Joren (2018) Percutaneous Coronary Intervention of Chronic Total Occlusions: Exploring the Final Frontier.-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
Appears in Collections:PhD theses
Research publications
Files in This Item:
File Description SizeFormat 
Doctoral_Thesis_Joren_Maeremans_Definitief digitale versie met cover.pdf4.52 MBAdobe PDFView/Open
Show simple item record

Page view(s)

22
checked on Sep 7, 2022

Download(s)

12
checked on Sep 7, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.